Fenoldopam does not prevent contrast-induced nephropathy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1413, 2003-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of contrast-induced nephropathy

By  

Reactions Weekly, Vol. 1, Iss. 1370, 2011-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Urinary Alkalinisation with Oral Sodium Bicarbonate for Patients at Risk of Contrast‐Induced Nephropathy

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 2, 2012-06 ,pp. : 118-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stability of a Formulated N‐acetylcysteine Capsule for Prevention of Contrast‐Induced Nephropathy

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 3, 2008-09 ,pp. : 219-222

John Wiley & Sons Inc

Access to resources Recommend Favorite

N-Acetylcysteine and Other Preventive Measures for Contrast-Induced Nephropathy in the Intensive Care Unit

By  

Current Medicinal Chemistry, Vol. 13, Iss. 21, 2006-09 ,pp. : 2565-2570

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment of Urinary N-Acetyl-β-glucosaminidase as an Early Marker of Contrast-induced Nephropathy

By Ren L   Ji J   Fang Y   Jiang SH   Lin YM   Bo J   Qian JY   Xu XH   Ding XQ  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 647-653

Field House Publishing

Access to resources Recommend Favorite